Table 2 Extrapolated human dosimetry for [⁶⁸Ga]NODAGA-RGDyK

Adrenals

7.40E−03

4.62E−03

1.48E−02

1.12E−02

5.88E−03

Brain

1.68E−03

1.87E−03

6.11E−03

7.36E−03

3.75E−03

Breasts

2.09E−03

2.16E−03

6.78E−03

7.95E−03

4.09E−03

Oesophagus

2.85E−03

2.60E−03

7.67E−03

8.29E−03

4.29E−03

Eyes

1.69E−03

1.88E−03

6.11E−03

7.36E−03

3.75E−03

Gallbladder wall

5.40E−03

3.81E−03

1.12E−02

9.91E−03

5.50E−03

Left colon^†

1.24E−02

4.01E−03

3.01E−02

1.18E−02

4.49E−03

Small Intestine^†

2.42E−02

7.20E−03

4.53E−02

1.64E−02

4.43E−03

Stomach Wall^†

9.20E−03

3.54E−03

2.17E−02

1.05E−02

4.52E−03

Right colon^†

1.27E−02

4.06E−03

3.06E−02

1.19E−02

4.65E−03

Rectum^†

1.56E−02

7.63E−03

3.31E−02

1.54E−02

4.37E−03

Heart wall^†

4.37E−03

3.71E−03

1.08E−02

1.04E−02

4.55E−03

Kidneys^†

2.71E−02

8.93E−03

5.86E−02

1.96E−02

9.42E−03

Liver^†

2.81E−02

1.59E−02

3.21E−02

1.87E−02

1.56E−02

Lungs^†

4.13E−03

6.01E−03

8.79E−03

1.35E−02

4.15E−03

Ovaries

5.38E−03

5.11E−03

1.15E−02

1.21E−02

4.84E−03

Pancreas

4.44E−03

3.19E−03

1.05E−02

9.49E−03

5.01E−03

Prostate

5.86E−03

5.75E−03

1.08E−02

1.14E−02

3.93E−03

Salivary glands

1.79E−03

1.99E−03

6.45E−03

7.77E−03

3.95E−03

Red Marrow^†

4.21E−03

3.64E−03

1.19E−02

1.11E−02

3.42E−03

Osteogenic cells

2.82E−03

2.54E−03

8.41E−03

8.29E−03

2.96E−03

Spleen^†

1.68E−02

9.87E−03

2.30E−02

1.41E−02

4.41E−03

Testes

2.48E−03

2.64E−03

6.69E−03

7.82E−03

3.54E−03

Thymus

2.31E−03

2.47E−03

7.26E−03

8.55E−03

4.23E−03

Thyroid

1.94E−03

2.13E−03

6.61E−03

7.94E−03

3.99E−03

Urinary bladder Wall^†

1.59E−01

1.59E−01

1.64E−01

1.64E−01

4.12E−03

Uterus

9.09E−03

8.61E−03

1.54E−02

1.55E−02

4.82E−03

Total body

4.39E−03

3.80E−03

9.83E−03

9.83E−03

4.39E−03

Effective dose (mSv/MBq)

1.32E−02

1.06E−02

2.09E−02

1.66E−02

4.25E−03